Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gibbs

Showing results (161-170 of 427) with videos related to

Pageof 43
Sort By:
Cancer Medicine|July 13, 2024
Trends in primary care blood tests prior to lung and colorectal cancer diagnosis-A retrospective cohort study using linked Australian dataMeena Rafiq, Allison Drosdowsky, Ben Solomon, et al.
Asia-Pacific Journal of Clinical Oncology|November 23, 2021
Treatment and outcomes of unresectable and metastatic pancreatic cancer treated in public and private Australian hospitalsYat Hang To, Julia Shapiro, Rachel Wong, et al.
Epidemiology and Psychiatric Sciences|March 31, 2026
Modifiable psychosocial factors associated with psychological distress, depression, anxiety and self-rated health among Aboriginal and Torres Strait Islander populationsSubash Thapa, Julaine Allan, Santosh Giri, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2024
Measuring quality in the care of metastatic colorectal cancer utilising available registry data: A modified Delphi studyCatherine Dunn, Jeremy Shapiro, Margaret Lee, et al.
Asia-Pacific Journal of Clinical Oncology|October 20, 2020
Patterns of surveillance for colorectal cancer: Experience from a single large tertiary institutionSamantha A Pellegrino, Steven Chan, Koen Simons, et al.
Journal of Cancer Research and Clinical Oncology|May 16, 2025
Artificial intelligence generated 3D body composition predicts dose modifications in patients undergoing neoadjuvant chemotherapy for rectal cancerAlex Besson, Ke Cao, Ahmed Mardinli, et al.
Future Oncology (London, England)|July 14, 2018
Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyondHui-Li Wong, Michael Christie, Lucy Gately, et al.
Molecular Imaging and Biology|March 9, 2019
Pre-Therapeutic Total Lesion Glycolysis on [<sup>18</sup>F]FDG-PET Enables Prognostication of 2-Year Progression-Free Survival in MALT Lymphoma Patients Treated with CD20-Antibody-Based ImmunotherapyMarius E Mayerhoefer, Anton Staudenherz, Barbara Kiesewetter, et al.
Journal of the National Cancer Institute|November 27, 2008
Re: Residual treatment disparities after oncology referral for rectal cancerKathryn M Field, Suzanne Kosmider, Jayesh Desai, et al.
ANZ Journal of Surgery|November 18, 2022
Current colorectal cancer chemotherapy dosing limitations and novel assessments to personalize treatmentsYasser Arafat, Matthew Loft, Ke Cao, et al.
Pageof 43

Showing results (161-170 of 427) with videos related to

Sort By:
Pageof 43
Cancer Medicine|July 13, 2024
Trends in primary care blood tests prior to lung and colorectal cancer diagnosis-A retrospective cohort study using linked Australian dataMeena Rafiq, Allison Drosdowsky, Ben Solomon, et al.
Asia-Pacific Journal of Clinical Oncology|November 23, 2021
Treatment and outcomes of unresectable and metastatic pancreatic cancer treated in public and private Australian hospitalsYat Hang To, Julia Shapiro, Rachel Wong, et al.
Epidemiology and Psychiatric Sciences|March 31, 2026
Modifiable psychosocial factors associated with psychological distress, depression, anxiety and self-rated health among Aboriginal and Torres Strait Islander populationsSubash Thapa, Julaine Allan, Santosh Giri, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2024
Measuring quality in the care of metastatic colorectal cancer utilising available registry data: A modified Delphi studyCatherine Dunn, Jeremy Shapiro, Margaret Lee, et al.
Asia-Pacific Journal of Clinical Oncology|October 20, 2020
Patterns of surveillance for colorectal cancer: Experience from a single large tertiary institutionSamantha A Pellegrino, Steven Chan, Koen Simons, et al.
Journal of Cancer Research and Clinical Oncology|May 16, 2025
Artificial intelligence generated 3D body composition predicts dose modifications in patients undergoing neoadjuvant chemotherapy for rectal cancerAlex Besson, Ke Cao, Ahmed Mardinli, et al.
Future Oncology (London, England)|July 14, 2018
Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyondHui-Li Wong, Michael Christie, Lucy Gately, et al.
Molecular Imaging and Biology|March 9, 2019
Pre-Therapeutic Total Lesion Glycolysis on [<sup>18</sup>F]FDG-PET Enables Prognostication of 2-Year Progression-Free Survival in MALT Lymphoma Patients Treated with CD20-Antibody-Based ImmunotherapyMarius E Mayerhoefer, Anton Staudenherz, Barbara Kiesewetter, et al.
Journal of the National Cancer Institute|November 27, 2008
Re: Residual treatment disparities after oncology referral for rectal cancerKathryn M Field, Suzanne Kosmider, Jayesh Desai, et al.
ANZ Journal of Surgery|November 18, 2022
Current colorectal cancer chemotherapy dosing limitations and novel assessments to personalize treatmentsYasser Arafat, Matthew Loft, Ke Cao, et al.
Pageof 43